This week on Contemporary OB/GYN®: August 16 to August 20

You can expect a variety of topics this week, including:

FDA accepts pembrolizumab as singlea agent for treatment of advanded endometrial cancer

New biomarker could predict immunotherapy benefit in breast cancer

New Hampshire's abortion restrictions

Oral contraceptives and risk of cardiac events in women with congenital long-QT syndrome

The impact of nutrition on gynecological diseases